课题基金 / 基金详情

Analysis of Mucosal Immunity by the Fc receptor for IgA and IgM

Analysis of Mucosal Immunity by the Fc receptor for IgA and IgM
IgA 和 IgM Fc 受体的粘膜免疫分析
批准号:
14207024
负责人:
SHIBUYA Akira
金额:
$27.62万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

SHIBUYA Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We previously identified an Fc receptor for IgA and IgM (Fcα/μ receptor), which is expressed on antigen presenting cells. We found that the Fcα/μ receptor mediated endocytosis of IgM immune complex with antigen, such as staphylococcus aureus, suggesting an important mechanisms of pathogen eradication by IgM. The present study aims to clarify a role of the Fcα/μ receptor in mucosal immunity. We have identified several isoforms of the soluble Fcα/μ receptor expressed on intestinal Paneth cells and epithelial cells of urinary tract. We found that the extracellular domain of the isoforms may have antimicrobial activity against E.coli. Furthermore, we observed that mice deficient in the Fcα/μ receptor gene exhibited high IgA concentration in both serum and fecus and the presence of many IgA producing cells in lamina proplia.We also observed that the Fcα/μ receptor was strongly expressed on the area of germinal center. Immunohistochemical study revealed that FDC substantially expressed the Fcα/μ receptor in germinal center. These results suggest that the Fcα/μ receptor regulates IgA production in peyel's patches and/or intestinal flora by the soluble Fcα/μ receptor secreted from Paneth cells. Furthermore, we studied the mucosal immune responses by antigen challenge in mice deficient in the the Fcα/μreceptor gene.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Successful gene transfer into human CD4 positive T cells mediated by lentiviral vectors.
由慢病毒载体介导成功地将基因转移到人类 CD4 阳性 T 细胞中。
DOI: --
发表时间: 2004
期刊: Immunology 12
影响因子: --
作者: [Shibuya K, et al.]
通讯作者: et al.
Kojima H., Shibuya A.et al.: "CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells"J.Biol.Chem.. 278・367. 48-53 (2003)
小岛H.、涩谷A.等:“CD226介导血小板和巨核细胞与血管内皮细胞的粘附”J.Biol.Chem.. 278・367(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Requirement of the serine at residue 329 for lipid raft recruitmet of DNAM-1 (CD226)
DNAM-1 (CD226) 脂筏招募需要残基 329 处的丝氨酸
DOI: --
发表时间: 2005
期刊: Int Immunol 17
影响因子: --
作者: [Shirakawa J, Shibuya K, Shibuya, A.]
通讯作者: A.
Requirement of the tyrosines at residues 258 and 270 of MAIR-1 in inhibitory effect on degranulation from basophilic leukemia RBL-2H3.
MAIR-1 残基 258 和 270 处的酪氨酸对嗜碱性白血病 RBL-2H3 脱粒的抑制作用的需要。
DOI: --
发表时间: 2005
期刊: International Immunology 17
影响因子: --
作者: [Suto A, Nakajima H, Takatori H, Tokumasa N, Suzuki K, Iwamoto I, Shirakawa J et al., Shibuya A et al., Okoshi Y et al.]
通讯作者: Okoshi Y et al.
14
    Development of the therapy for allergic airway hypersensitivity by using a phospholipid liposome
    • 批准号:
      16K15455
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      SHIBUYA Akira
    • 依托单位:
    The immunopathological study on leukocyte adhesion molecule DNAM-1 (CD226)
    • 批准号:
      21249026
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.87万
    • 财政年份:
      2009
    • 负责人:
      SHIBUYA Akira
    • 依托单位:
    Development of immunotherapy for DNAM-1 as a molecular target in graft-versus-host disease
    • 批准号:
      19390257
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      SHIBUYA Akira
    • 依托单位:
    Molecular base of the defenses against infection by IgM and IgA
    • 批准号:
      16017215
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $9.6万
    • 财政年份:
      2004
    • 负责人:
      SHIBUYA Akira
    • 依托单位:
    国内基金
    Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
    • 批准号:
      82371007
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      雷浪
    • 依托单位:
    Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      傅强
    • 依托单位:
    丹参酮ⅡA通过靶向TRAIL-receptor和ULBPs增强NK细胞抗非小细胞肺癌效应的作用及分子机制研究
    • 批准号:
      81903932
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2019
    • 负责人:
      龚陈媛
    • 依托单位:
    白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究